MedTrace Logo

A Proof of Science, Dose-Response Study to Evaluate the Safety, Efficacy of Different Dosages of Test Treatments

NCT05613660 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 264

Last updated 2023-12-12

No results posted yet for this study

Summary

A proof of science clinical study with randomized, four-arm, comparative, single-blind, within the arm - Dose-Response Study to evaluate the safety and efficacy of different collagen peptide-containing test treatments in adult human subjects.

The dose-response will be evaluated for the effectiveness of each test treatment in three different dosages that is 2.5 g Versus 5 g Versus 10 g.

22 subjects will be enrolled per dose per test treatment to complete 20 subjects per dose per test treatment.

Conditions

  • Mild to Moderate Acne
  • Stiffness of Joint, Nec, Involving Ankle and Foot in MDR24_1
  • Other Specified Diseases of Hair and Hair Follicles
  • Brittle Nails
  • Osteoarthritis, Knee
  • Healthy

Interventions

DIETARY_SUPPLEMENT

Veg Collagen Peptide

Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water

DIETARY_SUPPLEMENT

Bovine Collagen Peptide

Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water

DIETARY_SUPPLEMENT

Fish | Marine Collagen Peptide

Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water

DIETARY_SUPPLEMENT

Chicken Collagen Peptide

Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water

Sponsors & Collaborators

  • Collagen Lifesciences Private Limited

    collaborator UNKNOWN

  • NovoBliss Research Pvt Ltd

    lead OTHER

Principal Investigators

  • Dr Nayan K Patel, MBBS · Medical Director

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-11
Primary Completion
2023-04-30
Completion
2023-06-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05613660 on ClinicalTrials.gov